Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|November 7, 2017
Anticancer cellular immunotherapies derived from umbilical cord bloodKatalin Balassa, Vanderson Rocha
British Journal of Hospital Medicine (London, England : 2005)|December 29, 2018
Haematopoietic stem cell transplants: principles and indicationsKatalin Balassa, Robert Danby, Vanderson Rocha
British Journal of Haematology|November 4, 2014
NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myelomaGergely Varga, Gábor Mikala, Hajnalka Andrikovics, et al.
Pediatric Transplantation|July 2, 2019
Cardiometabolic correlates of sleep-disordered breathing in renal transplant childrenZsófia Lendvai, Krisztina Pásti, Lilla Szeifert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2015
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100Tunde Krahling, Katalin Balassa, Katalin Piroska Kiss, et al.
Orvosi Hetilap|December 22, 2014
[Complex molecular genetic algorithm in the diagnosis of myeloproliferative neoplasms]Tünde Krähling, Katalin Balassa, Nóra Meggyesi, et al.
Bone Marrow Transplantation|September 19, 2019
Investigation of TGFB1 -1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantationPetra Kövy, Nóra Meggyesi, Lívia Varga, et al.
Orvosi Hetilap|February 21, 2017
[Allogeneic hematopoietic stem cell transplantation in Hungary]Árpád Bátai, Péter Reményi, Marienn Réti, et al.
Haematologica|June 5, 2014
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutationsHajnalka Andrikovics, Tunde Krahling, Katalin Balassa, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2017
Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple MyelomaGergely Varga, Gábor Mikala, Katalin Piroska Kiss, et al.
Pageof 2